Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Crinetics Pharmaceuticals (CRNX) is now available.
Marc Wilson has announced his resignation as the Chief Financial Officer of the Company, effective once a successor is found and transitioned into the role. The company is actively searching for a new CFO. Wilson’s decision to leave is due to personal reasons and not due to any disputes or disagreements with the company’s operations or practices.
For detailed information about CRNX stock, go to TipRanks’ Stock Analysis page.